Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider.
Crit Care
; 24(1): 603, 2020 10 09.
Article
in English
| MEDLINE | ID: covidwho-844291
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Critical Illness
/
Coronavirus Infections
/
Pandemics
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
Crit Care
Year:
2020
Document Type:
Article
Affiliation country:
S13054-020-03294-7
Similar
MEDLINE
...
LILACS
LIS